prescription drugs healthcare

Bipartisan effort presses Biden administration to prevent prescription drug cost increases for low-income households

Rebecca Barnabi

U.S. Rep. Abigail Spanberger is leading a bipartisan effort with 180 colleagues to encourage the Biden Administration “to prevent reckless prescription drug cost hikes and defend the 340B Drug Pricing Program in the face of illegal actions from several pharmaceutical companies.”